TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 32 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $7,201,000 | -21.9% | 670,459 | +7.0% | 0.55% | -32.5% |
| Q4 2020 | $9,220,000 | +0.5% | 626,759 | -2.9% | 0.82% | -9.2% |
| Q3 2020 | $9,172,000 | -3.8% | 645,435 | -45.2% | 0.90% | +0.4% |
| Q2 2020 | $9,533,000 | +87.2% | 1,178,346 | -6.5% | 0.90% | +40.8% |
| Q1 2020 | $5,093,000 | +160.5% | 1,260,694 | +852.9% | 0.64% | +100.3% |
| Q3 2016 | $1,955,000 | +64.6% | 132,300 | 0.0% | 0.32% | +3.2% |
| Q2 2016 | $1,188,000 | -2.9% | 132,300 | 0.0% | 0.31% | +16.2% |
| Q1 2016 | $1,224,000 | -26.6% | 132,300 | 0.0% | 0.26% | +8.6% |
| Q4 2015 | $1,668,000 | -12.9% | 132,300 | -10.0% | 0.24% | 0.0% |
| Q3 2015 | $1,915,000 | -40.3% | 147,000 | 0.0% | 0.24% | -22.3% |
| Q2 2015 | $3,208,000 | +66.9% | 147,000 | +54.7% | 0.31% | +57.0% |
| Q1 2015 | $1,922,000 | – | 95,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
| Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
| COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
| Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
| Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
| ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
| NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
| Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
| Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |